Breaking News Instant updates and real-time market news.

ITW

Illinois Tool Works

$138.37

-1.05 (-0.75%)

17:59
08/20/18
08/20
17:59
08/20/18
17:59

Illinois Tool Works initiated with an Equal Weight at Morgan Stanley

Morgan Stanley analyst Joshua Pokrzywinski initiated Illinois Tool Works with an Equal Weight rating and a price target of $146. The analyst notes that while the company is "positioned as a defensive industrial" based on the high quality nature of its portfolio, its markets are cyclical, with less room for margin expansion to come in the next 12 months. While he does not believe that Illinois Tool Works cut operating costs "too deep to grow", he notes that "there has been both organic and M&A opportunity cost" in its capital decision.

ITW Illinois Tool Works
$138.37

-1.05 (-0.75%)

07/24/18
RBCM
07/24/18
NO CHANGE
Target $150
RBCM
Sector Perform
Illinois Tool Works price target lowered to $150 from $165 at RBC Capital
RBC Capital analyst Seth Weber lowered his price target on Illinois Tool Works to $150 and kept his Sector Perform rating after its Q2 results. The analyst states that while the company delivered "solid organic revenue growth" with operating initiatives supported by good returns, its capped operating margin and EPS outlook for FY18 could "take some air" out of the investment story.
07/24/18
SBSH
07/24/18
NO CHANGE
Target $166
SBSH
Buy
Illinois Tool Works selloff yesterday a buying opportunity, says Citi
Citi analyst Andrew Kaplowitz recommends using the selloff yesterday in shares of Illinois Tool Works as a buying opportunity. Despite "disappointing" guidance, the fundamental strengths of Illinois Tool Works' "diversified" portfolio and focused business model is not materially changed, Kaplowitz tells investors in a post-earnings research note. He believes the currency and cost headwinds pressuring the near-term outlook should detract from the company's "durable strengths." Kaplowitz lowered his price target for Illinois Tool Works to $166 from $187 and keeps a Buy rating on the name.
07/24/18
FBCO
07/24/18
NO CHANGE
Target $146
FBCO
Neutral
Illinois Tool Works price target lowered to $146 from $166 at Credit Suisse
Credit Suisse analyst Jamie Cook lowered his price target for Illinois Tool Works to $146 from $166 after the company reported an in-line quarter but lowered full year guidance by 10c largely on FX. The analyst reiterates a Neutral rating on the shares.
07/24/18
WELS
07/24/18
NO CHANGE
Target $160
WELS
Outperform
Illinois Tool Works price target lowered to $160 from $170 at Wells Fargo
Wells Fargo analyst Andrew Casey lowered his price target for Illinois Tool Works to $160 from $170 as its underlying investment case hit another pothole in Q2. In the short-term, the analyst believes the company's operating profit shortfall and decreased earnings guidance likely weighed on the stock. Nonetheless, Casey believes the underlying fundamentals remain solid, and the selloff presents a good entry point. He reiterates an Outperform rating on the shares.

TODAY'S FREE FLY STORIES

GOOG

Alphabet

$1,166.21

-20.87 (-1.76%)

, GOOGL

Alphabet Class A

$1,172.22

-19.34 (-1.62%)

06:26
09/24/18
09/24
06:26
09/24/18
06:26
Periodicals
White House considers antitrust probe at Google, Facebook for 'bias,' BI says »

The White House is…

GOOG

Alphabet

$1,166.21

-20.87 (-1.76%)

GOOGL

Alphabet Class A

$1,172.22

-19.34 (-1.62%)

FB

Facebook

$162.90

-3.16 (-1.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 21

    Oct

  • 25

    Oct

  • 25

    Oct

  • 28

    Oct

  • 03

    Mar

AMAL

Amalgamated Bank

$18.69

0.57 (3.15%)

06:26
09/24/18
09/24
06:26
09/24/18
06:26
Earnings
Amalgamated Bank reports Q2 core EPS 40c, consensus 34c »

Net Interest Margin was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NTNX

Nutanix

$46.55

-1.43 (-2.98%)

06:25
09/24/18
09/24
06:25
09/24/18
06:25
Downgrade
Nutanix rating change  »

Nutanix downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 10

    Dec

HZNP

Horizon Pharma

$18.82

-0.02 (-0.11%)

06:25
09/24/18
09/24
06:25
09/24/18
06:25
Recommendations
Horizon Pharma analyst commentary  »

Piper reiterates…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 27

    Nov

NTNX

Nutanix

$46.55

-1.43 (-2.98%)

06:25
09/24/18
09/24
06:25
09/24/18
06:25
Syndicate
Breaking Syndicate news story on Nutanix »

Nutanix files to sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 25

    Oct

  • 29

    Oct

  • 10

    Dec

APO

Apollo Global

$36.08

0.87 (2.47%)

, ATH

Athene Holding

$53.37

0.17 (0.32%)

06:23
09/24/18
09/24
06:23
09/24/18
06:23
Periodicals
Apollo criticized over scale of fees to affiliate life insurer, FT reports »

Imran Siddiqui, a former…

APO

Apollo Global

$36.08

0.87 (2.47%)

ATH

Athene Holding

$53.37

0.17 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

, SHPG

Shire

$178.32

-1.68 (-0.93%)

06:22
09/24/18
09/24
06:22
09/24/18
06:22
Periodicals
Top Takeda investor 'skeptical' about Shire takeover bid, Sunday Times reports »

One of the top 10…

TKPYY

Takeda Pharmaceutical

$0.00

(0.00%)

SHPG

Shire

$178.32

-1.68 (-0.93%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

  • 03

    Oct

  • 03

    Oct

  • 22

    Oct

  • 21

    Dec

AGTC

Applied Genetic

$4.40

-0.05 (-1.12%)

, NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

06:20
09/24/18
09/24
06:20
09/24/18
06:20
Upgrade
Applied Genetic, Nightstar Therapeutics, Biogen rating change  »

Applied Genetic upgraded…

AGTC

Applied Genetic

$4.40

-0.05 (-1.12%)

NITE

Nightstar Therapeutics

$25.64

-1.71 (-6.25%)

BIIB

Biogen

$343.77

2.49 (0.73%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

  • 03

    Oct

  • 16

    Oct

  • 17

    Oct

  • 22

    Oct

AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

, WMT

Walmart

$95.85

0.1 (0.10%)

06:17
09/24/18
09/24
06:17
09/24/18
06:17
Periodicals
FreshDirect's deliveries stumble amid move, increased competition, WSJ reports »

FreshDirect says…

AMZN

Amazon.com

$1,917.75

-26.51 (-1.36%)

WMT

Walmart

$95.85

0.1 (0.10%)

KR

Kroger

$29.95

0.77 (2.64%)

ADRNY

Ahold Delhaize

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

  • 15

    Nov

  • 03

    Mar

KRP

Kimbell Royalty Partners

$22.15

0.01 (0.05%)

06:17
09/24/18
09/24
06:17
09/24/18
06:17
Hot Stocks
Kimbell Royalty Partners changes tax status to taxable entity »

Kimbell Royalty Partners…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SFM

Sprouts Farmers Market

$27.53

0.01 (0.04%)

06:16
09/24/18
09/24
06:16
09/24/18
06:16
Downgrade
Sprouts Farmers Market rating change  »

Sprouts downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Oct

AKTS

Akoustis

$8.20

-0.15 (-1.80%)

06:16
09/24/18
09/24
06:16
09/24/18
06:16
Recommendations
Akoustis analyst commentary  »

Akoustis on track to meet…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CMCSA

Comcast

$37.91

0.1 (0.26%)

, CMCSK

Comcast

$0.00

(0.00%)

06:14
09/24/18
09/24
06:14
09/24/18
06:14
Periodicals
Comcast CEO pledges to preserve Sky's independence, FT reports »

Comcast (CMCSA, CMCSK)…

CMCSA

Comcast

$37.91

0.1 (0.26%)

CMCSK

Comcast

$0.00

(0.00%)

SKYAY

Sky

$0.00

(0.00%)

DIS

Disney

$110.72

-0.9 (-0.81%)

FOX

21st Century Fox

$43.97

-0.23 (-0.52%)

FOXA

21st Century Fox

$44.33

-0.26 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

WCG

WellCare

$304.42

2.41 (0.80%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Hot Stocks
WellCare elects former Louisiana governor Bobby Jindal to board »

WellCare Health Plans…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AERI

Aerie Pharmaceuticals

$58.50

0.1 (0.17%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Recommendations
Aerie Pharmaceuticals analyst commentary  »

Aerie Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 01

    Oct

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Periodicals
U.S., China impose new tariffs on each other's goods, Reuters reports »

The U.S. and China…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$292.03

-0.1774 (-0.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTSH

Cognizant

$77.63

0.45 (0.58%)

06:13
09/24/18
09/24
06:13
09/24/18
06:13
Hot Stocks
Michael Patsalos-Fox succeeds John Klein as Cognizant chairman »

Cognizant announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Oct

  • 22

    Oct

  • 16

    Nov

KVHI

KVH Industries

06:12
09/24/18
09/24
06:12
09/24/18
06:12
Upgrade
KVH Industries rating change  »

KVH Industries upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 25

    Sep

UNFI

United Natural Foods

$31.02

-2.81 (-8.31%)

06:12
09/24/18
09/24
06:12
09/24/18
06:12
Upgrade
United Natural Foods rating change  »

United Natural Foods…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Oct

KTWO

K2M Group

$27.30

0.02 (0.07%)

06:11
09/24/18
09/24
06:11
09/24/18
06:11
Downgrade
K2M Group rating change  »

K2M Group downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Oct

ANGI

Angi Homeservices

$22.53

-0.59 (-2.55%)

06:11
09/24/18
09/24
06:11
09/24/18
06:11
Conference/Events
Angi Homeservices management to meet with Oppenheimer »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

GHG

GreenTree Hospitality

$12.96

-0.54 (-4.00%)

06:11
09/24/18
09/24
06:11
09/24/18
06:11
Initiation
GreenTree Hospitality initiated  »

GreenTree Hospitality…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SA

Seabridge Gold

$11.25

-0.2 (-1.75%)

06:10
09/24/18
09/24
06:10
09/24/18
06:10
Hot Stocks
Seabridge Gold says KSM Project in British Columbia meeting objectives »

Seabridge Gold announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

ENDP

Endo

$16.11

-0.24 (-1.47%)

06:09
09/24/18
09/24
06:09
09/24/18
06:09
Hot Stocks
Endo agrees to additional stat of FDA litigation »

Endo International…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

HJLI

Hancock Jaffe Laboratories

$2.62

0.09 (3.56%)

06:08
09/24/18
09/24
06:08
09/24/18
06:08
Hot Stocks
Hancock Jaffe Laboratories submits application to INVIMA for VenoValve trial »

Hancock Jaffe…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.